LIPOPROTEIN(A) LEVELS IN NAFLD PATIENTS: A NOVEL BIOMARKER TO PREDICT HEPATIC FIBROSIS

被引：0

作者：

Meroni, Marica ^{[1
]}

Longo, Miriam ^{[1
,2
]}

Lombardi, Rosa ^{[3
,4
]}

Paolini, Erika ^{[5
]}

Macchi, Chiara ^{[6
]}

Corsini, Alberto ^{[6
]}

Sirtori, Cesare ^{[6
]}

Fracanzani, Anna Ludovica ^{[7
]}

Ruscica, Massimiliano ^{[6
]}

Dongiovanni, Paola ^{[1
]}

机构：

[1] Fdn Irccs Ca Granda Osped Maggiore Policlin, Gen Med & Metab Dis, Milan, Italy

[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[4] Fdn Irccs Ca Granda Osped Maggiore Policlin, Unit Internal Med & Metab Dis, Milan, Italy

[5] Fdn Irccs Ca Granda Osped Maggiore Policlin, Milan, Italy

[6] Univ Milan, Milan, Italy

[7] Univ Milan, Dept Pathophysiol & Transplantat, Unit Internal Med & Metab Dis, Policlin Hosp,Ca Granda Irccs Fdn, Milan, Italy

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1873

引用

页码：1114A / 1114A

页数：1

共 50 条

[21] Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis
Yu, Zhi
Nian, Caina
Sun, Wenmei
Liu, Xinhua
Nian, Xueyuan
CLINICA CHIMICA ACTA, 2024, 559
[22] Validation of the NAFLD Fibrosis Score in a Veterans Healthcare System Cohort of Patients to Noninvasively Identify Patients With Hepatic Fibrosis
Wang, Jeremy
Benhammou, Jihane N.
Kawamoto, Jenna K.
Pisegna, Joseph R.
May, Folasade P.
GASTROENTEROLOGY, 2016, 150 (04) : S717 - S717
[23] Evaluation of severity of hepatic fibrosis and steatosis in biopsy-proven NAFLD patients using MR imaging, transient elastography, and serum biomarker
Lee, Y. -S.
Kim, J. H.
Lee, C. H.
Yeon, J. E.
Byun, K. S.
JOURNAL OF HEPATOLOGY, 2018, 68 : S574 - S574
[24] Relation of ANGPTL4 with the Concentration of LPL and Hepatic Fibrosis in Patients with NAFLD
Alexandra Dominguez-Perez, Gabriela
Vera-Gomez, Eduardo
Hernandez-Patricio, Alejandro
Ariel Gutierrez-Buendia, Juan
De la Vega-Moreno, Karen
Ramiro Zamora-Aleman, Carlos
Salamanca-Garcia, Moises
Montoya-Ramirez, Jesus
Felipe Gaytan-Fuentes, Omar
Mondragon-Teran, Paul
Perez-Cabeza de Vaca, Rebeca
Antonio Suarez-Cuenca, Juan
METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
[25] PREVALENCE OF SIGNIFICANT HEPATIC FIBROSIS AND CIRRHOSIS ASSESSED BY THE NAFLD FIBROSIS SCORE IN PATIENTS ATTENDING THE DIABETIC CLINIC
Chin, J. L.
Chan, G.
Sin, P. S-P.
Siddiqui, Z.
O'Rathallaigh, E.
Aftab, A. Rahman
Courtney, G.
McGurk, C.
JOURNAL OF HEPATOLOGY, 2015, 62 : S829 - S829
[26] The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Angulo, Paul
Hui, Jason M.
Marchesini, Giulio
Bugianesi, Ellisabetta
George, Jacob
Farrell, Geoffrey C.
Enders, Felicity
Saksena, Sushma
Burt, Alastair D.
Bida, John P.
Lindor, Keith
Sanderson, Schuyler O.
Lenzi, Marco
Adams, Leon A.
Kench, James
Therneau, Terry M.
Day, Christopher P.
HEPATOLOGY, 2007, 45 (04) : 846 - 854
[27] Japanese herbal medicines in the prevention of hepatic fibrosis in NAFLD
Fujimoto, M.
Tsuneyama, K.
Kainuma, A.
Sekiya, N.
Takano, Y.
Shimada, Y.
MODERN PATHOLOGY, 2007, 20 : 279A - 280A
[28] Japanese herbal medicines in the prevention of hepatic fibrosis in NAFLD
Fujimoto, M.
Tsuneyama, K.
Kainuma, M.
Sekiya, N.
Takano, Y.
Shimada, Y.
LABORATORY INVESTIGATION, 2007, 87 : 279A - 280A
[29] TELOMERE SHORTENING ASSOCIATED WITH PROGRESSION OF HEPATIC FIBROSIS IN NAFLD
Reja, Debashis
Visaria, Aayush
Tawadros, Augustine
Pioppo, Lauren
Bhurwal, Abhishek
Rustgi, Vinod K.
GASTROENTEROLOGY, 2020, 158 (06) : S1448 - S1448
[30] SPRING IS A NOVEL REGULATOR OF HEPATIC LIPID METABOLISM AND PLASMA LIPOPROTEIN LEVELS
Hendrix, S.
Zelcer, N.
ATHEROSCLEROSIS, 2023, 379

← 1 2 3 4 5 →